Human Toxoplasma gondii infection in Nigeria: a systematic review and meta-analysis of data published between 1960 and 2019

被引:13
作者
Karshima, Solomon Ngutor [1 ]
Karshima, Magdalene Nguvan [2 ]
机构
[1] Univ Jos, Dept Vet Publ Hlth & Prevent Med, PMB 2084, Jos, Nigeria
[2] Modibbo Adama Univ Technol, Dept Parasitol & Entomol, Yola, Adamawa State, Nigeria
关键词
Geographical distribution; HIV patients; Normal individuals; Pregnant women; Prevalence; Toxoplasma gondii; HUMAN-IMMUNODEFICIENCY-VIRUS; PREGNANT-WOMEN; RISK-FACTORS; CEREBRAL TOXOPLASMOSIS; HIGH SEROPREVALENCE; IGG ANTIBODY; PREVALENCE; DIAGNOSIS; ELISA; SEROEPIDEMIOLOGY;
D O I
10.1186/s12889-020-09015-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Over 70% of the worlds' population is infected by Toxoplasma gondii; a pathogen capable of causing cerebral toxoplasmosis in HIV patients and neonatal complications like miscarriage, chorioretinitis, hydrocephalus, cerebral calcification and foetal death in the third trimester of pregnancy. In spite of this, the burden of this zoonotic pathogen is poorly understood in Nigeria. The aim of the present study therefore, is to determine the burden of T. gondii among normal individuals, HIV patients and pregnant women as well as the distribution of the infection across Nigeria. Methods Using the PRISMA guidelines, we conducted a systematic review and meta-analysis of data retrieved from six electronic databases (AJOL, Google Scholar, PubMed, Scopus, Science Direct and Web of Science). Pooled prevalence (PP) and heterogeneity were determined by the random-effects model and the Cochran's Q-test respectively. The quality of each study and publication bias were assessed by the 9 point Joanna Briggs Institute Critical Appraisal Instrument and the Egger's regression asymmetry test respectively, while the robustness of a pooled estimate was tested by the single study omission analysis. Results Exactly 5834 of the 16,230 individuals examined for T. gondii infection by 50 studies across 17 Nigerian States were positive for the infection. Overall PP was 32.92% (95% CI: 27.89, 38.37), with a range of 14.41% (95% CI: 5.32, 33.54) to 86.82% (95% CI: 66.13, 95.69) across sub-groups. Pooled prevalence was significantly higher (p < 0.001) among pregnant women (40.25%; 95% CI: 33.19, 47.73) and HIV patients (31.68, 95% CI: 20.53, 45.41) than normal individuals (23.32, 95% CI: 17.25, 30.75). T. gondii prevalence declined by over 58% during the 59 years reviewed. Conclusion Toxoplasma gondii infection is moderately prevalent in Nigeria. Highest prevalence estimates were observed among pregnant women and in the south-south region. For effective control of the disease in Nigeria, a holistic approach involving on-farm, environmental, public health and animal components are suggested.
引用
收藏
页数:15
相关论文
共 50 条
[41]   The global prevalence and risk factors of Toxoplasma gondii among foxes: A systematic review and meta-analysis [J].
Wei, Xin-Yu ;
Gao, Yang ;
Lv, Chuang ;
Wang, Wei ;
Chen, Yu ;
Zhao, Quan ;
Gong, Qing-Long ;
Zhang, Xiao-Xuan .
MICROBIAL PATHOGENESIS, 2021, 150
[42]   An updated meta-analysis of the association between Toxoplasma gondii infection and risk of epilepsy [J].
Sadeghi, Maryam ;
Riahi, Seyed Mohammad ;
Mohammadi, Mona ;
Saber, Vafa ;
Aghamolaie, Somayeh ;
Moghaddam, Solmaz Alizadeh ;
Aghaei, Shima ;
Javanian, Mostafa ;
Gamble, H. Ray ;
Rostami, Ali .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2019, 113 (08) :453-462
[43]   Anti-Toxoplasma gondii Antibodies in European Residents: A Systematic Review and Meta-Analysis of Studies Published between 2000 and 2020 [J].
Calero-Bernal, Rafael ;
Gennari, Solange Maria ;
Cano, Santiago ;
Salas-Fajardo, Martha Ynes ;
Rios, Arantxa ;
Alvarez-Garcia, Gema ;
Ortega-Mora, Luis Miguel .
PATHOGENS, 2023, 12 (12)
[44]   Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: A systematic review and meta-analysis [J].
Bisetegn, Habtye ;
Debash, Habtu ;
Ebrahim, Hussen ;
Mahmood, Naunian ;
Gedefie, Alemu ;
Tilahun, Mihret ;
Alemayehu, Ermiyas ;
Mohammed, Ousman ;
Feleke, Daniel Getacher .
HEALTH SCIENCE REPORTS, 2023, 6 (06)
[45]   Prevalence of Toxoplasma gondii infection in chickens in China during 1993-2021: a systematic review and meta-analysis [J].
Nie, Lan-Bi ;
Gong, Qing-Long ;
Wang, Qi ;
Zhang, Rui ;
Shi, Jun-Feng ;
Yang, Yang ;
Li, Jian-Ming ;
Zhu, Xing-Quan ;
Shi, Kun ;
Du, Rui .
PARASITOLOGY RESEARCH, 2022, 121 (01) :287-301
[46]   Prevalence of Toxoplasma gondii infection in animals of the Arabian Peninsula between 2000-2020: A systematic review and meta-analysis [J].
Abdelgadier, Asmaa ;
Assaad, Nada ;
Elhussein, Zaynab ;
Al-Marri, Abdulla M. ;
Suliman, Sami ;
Eltom, Khalid ;
Al-Mslemani, Ebtisam A. ;
Al-Zeyara, Abdul Azia ;
El Hussein, Abdel Rahim M. ;
Enan, Khalid A. .
VETERINARY MEDICINE AND SCIENCE, 2023, 9 (01) :471-480
[47]   The seroprevalence and distribution of Toxoplasma gondii in pigs in China from 2000 to 2023: a systematic review and meta-analysis [J].
Liu, Ping ;
Tang, Hao ;
Xu, Quangang ;
Dong, Yaqin ;
Chen, Feng ;
Zhao, Dazhuo ;
Tang, Bin ;
Sun, Xiangdong ;
Liu, Xiaolei ;
Liu, Mingyuan ;
Wang, Youming .
ANIMAL DISEASES, 2025, 5 (01)
[48]   The global seroprevalence of Toxoplasma gondii among wild boars: A systematic review and meta-analysis [J].
Rostami, Ali ;
Riahi, Seyed Mohammad ;
Fakhri, Yadollah ;
Saber, Vafa ;
Hanifehpour, Hooman ;
Valizadeh, Soghra ;
Gholizadeh, Majid ;
Pouya, Rokhsane Hosseini ;
Gamble, H. Ray .
VETERINARY PARASITOLOGY, 2017, 244 :12-20
[49]   ASSOCIATION BETWEEN TOXOPLASMA GONDII TYPES AND OUTCOMES OF HUMAN INFECTION: A META-ANALYSIS [J].
Xia, Jing ;
Cheng, Xin-Yu ;
Wang, Xiao-Jun ;
Peng, Hong-Juan .
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2017, 64 (03) :229-244
[50]   Prevalence of Toxoplasma gondii infection among animals in Algeria: A systematic review and meta-analysis [J].
Ouchetati, Imane ;
Ouchene-Khelifi, Nadjet Amina ;
Ouchene, Nassim ;
Khelifi, Manal ;
Dahmani, Ali ;
Haif, Asma ;
Zeroual, Faycal ;
Benakhla, Ahmed .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2021, 74